Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Payables (2024 - 2025)

Kairos Pharma (KAPA) has disclosed Payables for 2 consecutive years, with $676000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Payables changed N/A year-over-year to $676000.0, compared with a TTM value of $676000.0 through Jun 2025, changed N/A, and an annual FY2024 reading of $992000.0, changed N/A over the prior year.
  • Payables was $676000.0 for Q2 2025 at Kairos Pharma, down from $805000.0 in the prior quarter.
  • Across five years, Payables topped out at $2.3 million in Q3 2024 and bottomed at $676000.0 in Q2 2025.